Skip to content
OpenCapital
Get started

Dyne Therapeutics, Inc. DYN R&D

R&D at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$228.9M+1.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$173.25M+30.2%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$42.65M+16.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$100.87M-7.4%
Scholar Rock logo
Scholar RockSRRK
$51.81M+6.4%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.66M-31.5%

Segments

By product

See full
DYNE-251DM1$37.75M+79.0%
DYNE-101DM1$14.78M-67.5%

Other financials

Income statement

See full
Operating income-$125.3M-2.4%
Net income-$120.9M-4.8%
EPS (diluted)-$0.73+30.5%

Balance sheet

See full
Cash & equivalents$753.1M+59.5%
Total debt$168.7M+623%
Total equity$865.1M+29.3%
Total assets$1.1B+49.8%

Cash flow

See full
Operating cash flow-$144.9M-36.9%
CapEx$221.0K-77.5%
Free cash flow-$145.1M-35.8%

Valuation

See full
Market cap$3.27B+153%
Enterprise value$2.69B+228%

Returns & leverage

See full
Return on equity-58.9%-4.4pp
Debt / equity0.2×+0.2×
Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s R&D?
Dyne Therapeutics, Inc. (DYN) reported R&D of $100.89M in Q1 2026.
How has Dyne Therapeutics, Inc.'s R&D changed year-over-year?
Dyne Therapeutics, Inc.'s R&D decreased by 5.2% year-over-year, from $106.45M to $100.89M.
What is the long-term trend for Dyne Therapeutics, Inc.'s R&D?
Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s R&D has grown at a 34.6% compound annual growth rate (CAGR), from $121.31M to $398.33M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.